Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Predicting Severity from Electronic Health Records of Leprosy Patients using Ensemble Learning

Mehta J, Kalla M. IEEE. 2023 World Conference on Communication & Computing (WCONF). 2023;
Publication

The cross-cultural validation and adaptation of the Patient Health Questionnaire-9 (PHQ-9) and the Warwick-Edinburgh Mental Wellbeing scale (WEMWBS) amongst persons affected by leprosy in India.

van der Staaij J. Vrije Universiteit . Health Sciences. 2019;
Publication

Cross-cultural validation of the Patient Health Questionnaire (PHQ-9) and the Mental Wellbeing Scale (WEMWBS) among people affected by lymphatic filariasis, in India.

Ceelen N. Vrije Universiteit. Health Sciences. 2019;
Publication

The collaboration of ‘Active case finding campaign’ with the 'Leprosy case detection campaign': An important step towards tuberculosis elimination

Yadav S. IP Innovative Publication Pvt Ltd. IP Indian Journal of Immunology and Respiratory Medicine. 2023; 8 (2) : 41-43.
Download PDF
Publication

Renal Abnormalities in Leprosy: Understanding the Scope and Implication

Pandey S, Agarwal S, Raizada A, et al. MAK HILL Publications. International Journal of Tropical Medicine . 2023; 18 (1) : 74-80.
Download PDF
Publication

Role of cytopathology in diagnosing phaeohyphomycosis masquerading as nerve abscess in a lepromatous leprosy patient: A case report.

Yadav S, Chandana B, Panwar H, et al. International journal of surgery case reports. 2023;
Download PDF
Publication

Leprosy in India: Current Issues and Prospects

Dang H. K, Sahai R. Research Communications . 2023;
Download PDF
Publication

Clinico–epidemiological profile of patients of Hansen’s disease in a tertiary care centre in West Bengal

Reza S, Mondal A. K, Shome K, et al. Journal of Pakistan Association of Dermatologists. 2023; 33 (3) : 980-985.
Download PDF
Publication

Slit-skin smear in post kala-azar dermal leishmaniasis and leprosy: How a negative report for Leishman-Donovan bodies in Giemsa stain may indicate leprosy.

Chatterjee K, Yadav V, Ramesh V. JAAD international. 2023;
Download PDF
Publication

Involvement of Medical Colleges in Implementation of National Strategic Plan 2023-27 for Leprosy Elimination: A Roadmap

Kishore J, Paul B, Roy R. Epidemiology International. 2023; 8 (2) : 4-6.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 34
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD